Further, treating patients with hepatitis C genotype 1 and insulin resistance using metformin improves insulin sensitivity and increases SVR rate in patients who reached HOMA lower than 2 at week 24 of therapy and in women, in whom the therapy doubled the SVR rate [25]. The gene discussed is INS; the disease is Insulin resistance.